NewslettersHuman Immunology NewsUncategorizedCharacterization of INCB086550, a Potent and Novel Small-Molecule PD-L1 InhibitorBy Justin.choi - March 8, 2022061Scientists described the identification and characterization of INCB086550, a novel, oral, small-molecule PD-L1 inhibitor.[Cancer Discovery] 6445212 AAAAAAAA items 1 apa 0 default asc 1 172636 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract